Search E-Book
Express Pharma Magazine November 2025
Express Pharma October 2025
IN THIS ISSUE
COVER STORY: Driving India's Innovation Edge
EDITOR'S NOTE: Turning the tariff tight spot into a sweet spot
INTERVIEW:
• Dr Gráinne McNamara, Research Integrity/Publication Ethics Manager, S. Karger AG
• Emil Alexander Byström, CEO of SpinChem AB
• Ganesh Tripathy, SVP and Global Head, Sustainability & EHS, Piramal Pharma
RESEARCH:
• Cell therapy’s next chapter: Industry embraces in-vivo innovation
TECHNOLOGY:
• AI compass: Transforming pharma commercialization
POLICY:
• Jan Vishwas Act 2025: Decriminalization and penalization of drug offences through Compounding
AYUSH:
• Unani Medicine: At crossroads of tradition and modernity
Points to Consider for Cleaning Validation [PDA TR 29]
Analysis of 23 Elements in Wastewater by U.S. EPA Method 6020B Using ICPMS-2050
For the analysis of heavy metals in wastewater, the methods of the US Environmental Protection Agency (EPA) are considered reference for analysis worldwide. The US EPA published Method 6020B to control 23 metals in environmental water using ICP-MS. ICP-MS can analyze many elements at the ppt levels and allows for simultaneous analysis by directly introducing wastewater samples.
In this Application News, 23 elements in wastewater were analyzed using the ICPMS-2050. Analytical samples’ spike recovery tests and long-term stability tests were performed in accordance with the quality control (QC) requirements of the EPA Method 6020B.
British Pharmacopoeia 2025
New legally enforced standards, available from 1 August 2024. All European Pharmacopoeia texts included.
Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.
It includes approximately 4,000 monographs which are legally enforced by the Human Medicines Regulations 2012. Where a BP monograph exists, medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph.
All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and beyond.
New for the BP 2025
The BP 2025 supersedes the BP 2024 and becomes legally effective on 1 January 2025. This edition incorporates new monographs from both the BP and Ph. Eur. along with a significant number of revised monographs.
Monographs and BPCRS:
14 new BP monographs, 32 new Ph. Eur. monographs. Including two new monographs for Paracetamol Infusion and Paracetamol Oral Solution and a new monograph for Solifenacin Oral Suspension which is accompanied by additional information on the website. This information provides a case study demonstrating how users can scale monograph methods to reduce run times and solvent usage;
105 amended BP monographs.
All monographs from the Ph. Eur. 11th edition and Ph. Eur. supplements 11.1 to 11.5.
Ph. Eur. supplements 11.6 to 11.8 included as in-year online and download product updates.
Updated references to new BPCRS included in the BP 2025 to ensure that you remain compliant.
Ensure you get the best value access to the information you need. Choose from a range of flexible licenses and formats - including full online and offline access.
USP 2025 pdf free download (United State Pharmacopeia 48 - NF 43)







